422 related articles for article (PubMed ID: 18402518)
1. Gemcitabine in the treatment of metastatic pancreatic cancer.
Hilbig A; Oettle H
Expert Rev Anticancer Ther; 2008 Apr; 8(4):511-23. PubMed ID: 18402518
[TBL] [Abstract][Full Text] [Related]
2. [Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer].
Ohkawa S
Nihon Rinsho; 2006 Jan; 64 Suppl 1():198-202. PubMed ID: 16457249
[No Abstract] [Full Text] [Related]
3. Gemcitabine and platinum combinations in pancreatic cancer.
Philip PA
Cancer; 2002 Aug; 95(4 Suppl):908-11. PubMed ID: 12209670
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine: a cytidine analogue active against solid tumors.
Hui YF; Reitz J
Am J Health Syst Pharm; 1997 Jan; 54(2):162-70; quiz 197-8. PubMed ID: 9117804
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic pancreatic cancer.
Ko AH; Tempero MA
J Natl Compr Canc Netw; 2005 Sep; 3(5):627-36. PubMed ID: 16194454
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine--a major advance?
Thomas A; Steward WP
Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
[No Abstract] [Full Text] [Related]
7. Developments in metastatic pancreatic cancer: is gemcitabine still the standard?
Ying JE; Zhu LM; Liu BX
World J Gastroenterol; 2012 Feb; 18(8):736-45. PubMed ID: 22371633
[TBL] [Abstract][Full Text] [Related]
8. Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors.
Innamarato P; Morse J; Mackay A; Asby S; Beatty M; Blauvelt J; Kidd S; Mullinax JE; Sarnaik AA; Pilon-Thomas S
BMC Cancer; 2021 Jun; 21(1):756. PubMed ID: 34187428
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
Kleespies A; Jauch KW; Bruns CJ
Drug Resist Updat; 2006; 9(1-2):1-18. PubMed ID: 16621676
[TBL] [Abstract][Full Text] [Related]
10. Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
Saif MW
JOP; 2008 Mar; 9(2):91-8. PubMed ID: 18326919
[TBL] [Abstract][Full Text] [Related]
11. [Salvage chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer: survival benefit in selected patients].
Lee JL; Kim YT
Korean J Gastroenterol; 2008 Jul; 52(1):59-63. PubMed ID: 19077495
[No Abstract] [Full Text] [Related]
12. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
13. Metastatic pancreatic cancer 2008: is the glass less empty?
Nieto J; Grossbard ML; Kozuch P
Oncologist; 2008 May; 13(5):562-76. PubMed ID: 18515741
[TBL] [Abstract][Full Text] [Related]
14. Icotinib plus gemcitabine for metastatic pancreatic cancer: a case report.
Zhao J; Shen H; Hu HG; Huang JJ
World J Gastroenterol; 2015 Mar; 21(11):3441-6. PubMed ID: 25805958
[TBL] [Abstract][Full Text] [Related]
15. [Gemcitabine in elderly patients with unresectable pancreas cancer].
Hanada K; Hino F; Amano H; Ooe H; Hirota Y; Sasao S; Obayashi M; Kajiyama G
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2521-5. PubMed ID: 12506475
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics and metabolic pathway of gemcitabine during intravenous and intra-arterial delivery in unresectable pancreatic cancer patients.
Shamseddine AI; Khalifeh MJ; Mourad FH; Chehal AA; Al-Kutoubi A; Abbas J; Habbal MZ; Malaeb LA; Bikhazi AB
Clin Pharmacokinet; 2005; 44(9):957-67. PubMed ID: 16122282
[TBL] [Abstract][Full Text] [Related]
17. Conventional chemotherapy of advanced pancreatic cancer.
Giuliani F; Di Maio M; Colucci G; Perrone F
Curr Drug Targets; 2012 Jun; 13(6):795-801. PubMed ID: 22458526
[TBL] [Abstract][Full Text] [Related]
18. Current options for palliative treatment in patients with pancreatic cancer.
Ridwelski K; Meyer F
Dig Dis; 2001; 19(1):63-75. PubMed ID: 11385253
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine. New first-line therapy for pancreatic cancer.
King RS
Cancer Pract; 1996; 4(6):353-4. PubMed ID: 9128490
[TBL] [Abstract][Full Text] [Related]
20. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
Gourgou-Bourgade S; Bascoul-Mollevi C; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Boige V; Bérille J; Conroy T
J Clin Oncol; 2013 Jan; 31(1):23-9. PubMed ID: 23213101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
